Myasthenia Gravis
Myasthenia Gravis, chronic disease marked by progressive weakness and abnormally rapid fatigue of the voluntary muscles. The muscles affected include those used in walking, breathing, chewing, and talking. A characteristic sign of the disease is drooping eyelids. Myasthenia gravis most often affects women between the ages of 20 and 30, but it can strike anyone after adolescence; after 40, it actually afflicts more men than women.
Myasthenia gravis is a noninherited autoimmune disease characterized by the presence of antibodies in the blood that destroy muscle-cell sites for the reception of acetylcholine molecules. Acetylcholine normally transmits signals between nerves and muscles, so when its receptors are destroyed it cannot induce muscle contractions. No cure for the disease yet exists, but it can be treated with drugs called anticholinesterases. These drugs are capable of inhibiting an enzyme, acetylcholinesterase, that breaks down acetylcholine in the body. Myasthenia gravis may also be relieved by surgical removal of the thymus and by a blood-cleansing process called plasmapheresis that eliminates the destructive antibodies.
Myasthenia gravis is a noninherited autoimmune disease characterized by the presence of antibodies in the blood that destroy muscle-cell sites for the reception of acetylcholine molecules. Acetylcholine normally transmits signals between nerves and muscles, so when its receptors are destroyed it cannot induce muscle contractions. No cure for the disease yet exists, but it can be treated with drugs called anticholinesterases. These drugs are capable of inhibiting an enzyme, acetylcholinesterase, that breaks down acetylcholine in the body. Myasthenia gravis may also be relieved by surgical removal of the thymus and by a blood-cleansing process called plasmapheresis that eliminates the destructive antibodies.